NasdaqCM - Nasdaq Real Time Price USD

Movano Inc. (MOVE)

0.8500

-0.0329

(-3.73%)

As of 11:49:27 AM EDT. Market Open.

Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements

Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced positive results of its most recent 81-participant blood pressure clinical study. Movano Health's prototype demonstrated a level of accuracy well within the standards recognized by the FDA for blood pressure monitoring devices, achieving an overall mean absolute difference (MAD) of 4.9 mmHg, which significantly exceeds the 7 mmHg MAD threshold required per a standard for wearable, cuffless blood pressure measuring devi

PR Newswire 7 days ago

MOVE
-3.73%
Movano's Evie Ring Adds New Personalization and Trend Tracking to Support Women's Wellness Journey

Movano Health (Nasdaq: MOVE), a pioneer in health technology and maker of the Evie Ring, today announced a series of new data personalization, trend tracking and integration features on the ring's companion app that expand support for women's wellness journeys. The enhancements follow January's beta release of EvieAI, the first wearable-based virtual wellness assistant built exclusively with training data from medical journals.

PR Newswire last month

MOVE
-3.73%
Movano Health Commences Clinical Study with New Cuffless Blood Pressure Device

Movano Health (Nasdaq: MOVE) announced today that it has commenced a blood pressure clinical trial with its newly developed cuffless blood pressure wrist wearable. The study, which is expected to include at least 70 participants and be completed during the second week of February, utilizes the updated device to monitor pulse pressure waveforms in comparison with a hospital grade blood pressure device. The new wearable will also collect data on a host of other vital signs including pulse rate, bl

PR Newswire 2 months ago

MOVE
-3.73%
Movano Health Launches EvieAI Virtual Wellness Assistant

Movano Health (Nasdaq: MOVE) today announced the latest enhancement to its Evie smart ring for women with the beta release of EvieAI, the first wearable-based virtual wellness assistant trained exclusively with data from medical journals. The new feature enables Evie users to answer health questions quickly, reliably and securely through the ring's companion app.

PR Newswire 3 months ago

MOVE
-3.73%
Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors

Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced the expansion of its board of directors with the addition of Dr. Shaheen Wirk, a leader in healthcare dedicated investment with a track record of success in medicine, partnerships, and research.

PR Newswire 3 months ago

MOVE
-3.73%
Movano Health Receives FDA Clearance for EvieMED Ring

Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the pulse oximeter in its EvieMED Ring. The clearance enables Movano Health to pursue multi-billion dollar business opportunities for health monitoring solutions needed for applications such as clinical trials, post-clinical trial management, and remote patient monitoring for both healthcare providers and payors.

PR Newswire 4 months ago

MOVE
-3.73%
Movano Health Reports Q3 2024 Financial Results and Provides Business Update

Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update.

PR Newswire 5 months ago

MOVE
-3.73%
Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device

Movano Health Inc. (Nasdaq: MOVE) announced today that it has tested its newly developed blood pressure wrist wearable as part of its November 5th and 6th hypoxia clinical trial that took place at the University of California, San Francisco. The updated device features an additional 12 mmWave antennas which together with Movano Health's custom IC delivers enhanced data collection with less impact of placement while also featuring a slimmer design, making it easier and more comfortable to wear. I

PR Newswire 5 months ago

MOVE
-3.73%
Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024

Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report third quarter 2024 financial and operating results on Thursday November 14, 2024, after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same day at 2:00 pm PT/5:00 pm ET.

PR Newswire 5 months ago

MOVE
-3.73%
Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split

Movano Health (Nasdaq: MOVE) (the "Company") provided an update on an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split.

PR Newswire 5 months ago

MOVE
-3.73%
Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED

Movano Health (NASDAQ: MOVE) announced today that it has submitted a complete response package to the FDA as part of the final phase of the Company's 510(k) application review of the EvieMED Ring. The Company remains optimistic on EvieMED's potential for 510(k) clearance.

PR Newswire 5 months ago

MOVE
-3.73%
Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split

Movano Health (Nasdaq: MOVE) (the "Company") announced today that it has opened an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split.

PR Newswire 5 months ago

MOVE
-3.73%
Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'Amelio

Movano Health (Nasdaq: MOVE) today announced its first brand partnership with digital creator, wife, mom and entrepreneur Heidi D'Amelio. An icon in the wellness, fashion and beauty space, D'Amelio will share her experiences with Movano's Evie Ring with her more than 12 million Instagram and TikTok followers and also provide product feedback to help the Movano team fine-tune its roadmap for ongoing upgrades to the Evie app.

PR Newswire 5 months ago

MOVE
-3.73%
Movano Health Announces Reverse Stock Split

Movano Health (Nasdaq: MOVE) announced today that it will implement a 1-for-15 reverse stock split of the issued shares of its common stock (the "Reverse Stock Split"), effective at 12:01 a.m. Eastern time on October 29, 2024. The Company's common stock is expected to begin trading on a split-adjusted basis when the market opens on Tuesday, October 29, 2024, and will continue to trade on The Nasdaq Capital Market under the symbol "MOVE." The new CUSIP number for the common stock will be 62459M 2

PR Newswire 6 months ago

MOVE
-3.73%
Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase

Movano Health (Nasdaq: MOVE) announced today that it plans to submit updated responses next week to all clarifying questions that it recently received from the FDA as part of the final phase of the Company's 510(k) application review. The Company secured a positive resolution this summer after responding to initial FDA questions related to EvieMED's wellness features and metrics and remains optimistic on EvieMED's potential for 510(k) clearance.

PR Newswire 6 months ago

MOVE
-3.73%
Movano Health Provides Update on FDA Review of EvieMED Ring

Movano Health (Nasdaq: MOVE) announced today that the Company recently received additional clarifying questions from the FDA related to medical aspects of the EvieMED Ring, as part of the final phase of the Company's 510(k) application review process. The Company secured a positive resolution this summer after responding to initial FDA questions related to EvieMED's wellness features and metrics and remains optimistic on EvieMED's potential for 510(k) clearance.

PR Newswire 6 months ago

MOVE
-3.73%
Evie, Movano Health's Smart Ring for Women, is Back In Stock with Key Upgrades

Movano Health (Nasdaq: MOVE) today announced the immediate availability of its Evie Ring, the first smart ring designed specifically for women. The ring features the same industry-first, award-winning open design that accommodates fluctuations in finger size, and is accompanied by an updated app that enhances users' ability to track and understand key metrics vital to their health and wellness.

PR Newswire 7 months ago

MOVE
-3.73%
Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring

Movano Health (Nasdaq: MOVE) announced today that a productive in-person meeting with the FDA on August 15, 2024, resulted in a positive outcome regarding the EvieMED Ring's wellness features and metrics. Following this development, the Company will be working with the agency to move forward with the review process. The EvieMED Ring is a wearable device designed to not only provide medical device functionality through its pulse oximetry feature, but also offer numerous wellness metrics related t

PR Newswire 7 months ago

MOVE
-3.73%
Movano (NASDAQ:MOVE) Will Have To Spend Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Simply Wall St. 8 months ago

MOVE
-3.73%
Movano Health Reports Q2 2024 Financial Results and Provides Business Update

Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported second quarter 2024 results and provided a business update.

PR Newswire 8 months ago

MOVE
-3.73%

Performance Overview

Return	MOVE	S&P 500 (^GSPC)
YTD	-84.26%	-5.37%
1-Year	-87.68%	+8.79%
3-Year	-97.78%	+34.71%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Movano Inc. (MOVE)

Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements

Movano's Evie Ring Adds New Personalization and Trend Tracking to Support Women's Wellness Journey

Movano Health Commences Clinical Study with New Cuffless Blood Pressure Device

Movano Health Launches EvieAI Virtual Wellness Assistant

Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors

Movano Health Receives FDA Clearance for EvieMED Ring

Movano Health Reports Q3 2024 Financial Results and Provides Business Update

Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device

Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024

Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split

Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED

Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split

Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'Amelio

Movano Health Announces Reverse Stock Split

Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase

Movano Health Provides Update on FDA Review of EvieMED Ring

Evie, Movano Health's Smart Ring for Women, is Back In Stock with Key Upgrades

Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring

Movano (NASDAQ:MOVE) Will Have To Spend Its Cash Wisely

Movano Health Reports Q2 2024 Financial Results and Provides Business Update

Performance Overview